Live Breaking News & Updates on Astrazeneca vaccine efficacy

Stay informed with the latest breaking news from Astrazeneca vaccine efficacy on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Astrazeneca vaccine efficacy and stay connected to the pulse of your community

Oxford AstraZeneca vaccine efficacy: When will new adapted Oxford vaccine be available?

Oxford AstraZeneca vaccine efficacy: Boris Johnson said vaccines 'remain of massive benefit' to the UK (Image: GETTY)
READ MORE
But a recent study of some 2,000 young people has shown the Oxford vaccine only offers minimal protection against mild and moderate infection from the South African Covid variant.
However, the study could not conclude whether the vaccine also worked against severe disease due to the young age of the trial participants, who were on average aged 31.
Andrew Pollard, chief investigator on the Oxford vaccine trial, said: "This study confirms that the pandemic coronavirus will find ways to continue to spread in vaccinated populations, as expected.

South-africa , United-kingdom , France , Brazil , French , South-african , Andrew-pollard , Edward-argar , Oxford-astrazeneca , Sarah-gilbert , Andrew-neil , Nadhim-zahawi